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MicroRNAs (miRNAs) fine-tune target protein synthesis by suppressing gene expression,
temporally changing along development and possibly in pathological conditions.
A method to monitor the action of miRNAs in vivo shall help understand their
dynamic behavior during development. In this study, we established a transgenic mouse
harboring miR-124 responsive element in their luciferase-eGFP reporter transgenes
which enabled monitoring the action of miR-124 in the brain and other organs in vivo
by the bioluminescence imaging. The mouse model was produced and verified by
imaging ex vivo so that luminescence by luciferase shone and then reduced during
development with miR-124 expression. Bioluminescence dramatically decreased in the
brain between embryonic day 13 and 16 as endogenous miR-124 expression increased,
which sustained into adulthood. The inverse relationship of miR-124 expression was
observed with luciferase bioluminescence and activity ex vivo as well as in vivo. Taken
together, one can use this microRNA-transgenic mouse to investigate the temporal
changes of microRNA action in vivo in the brain as well as in other organs.
Keywords: mir-124, transgenic mouse, bioluminescence imaging, development, neurogenesis
INTRODUCTION
MicroRNAs (miRNAs), small endogenous non-coding RNAs of ∼22 nucleotides, regulate gene
expression post-transcriptionally in almost all types of cells of living organisms. MiRNAs
are transcribed by RNA polymerase II, which yields primary miRNA (pri-miRNA) in the
nucleus (Lee et al., 2004). The pri-mRNA is cut in its core by Drosha (endonuclease RNase
III), producing a 60∼70 nucleotide-long pre-miRNA (Lee et al., 2003). In the cytoplasm,
the pre-miRNA is released from the pre-RISC complex, and the molecule is cut by Dicer
(endonuclease RNase III). These processes lead to the production of mature single strand
miRNA (Hammond et al., 2000). The mature miRNA interacts with complementary sequence
situated within the 3′ untranslated region (3′UTR) of target mRNA, and these base-pairings
induce degradation and/or the translational inhibition of its target mRNAs (Bartel, 2009).
This opens the possibility of monitoring of mature miRNA action by transfecting reporter
transgenes harboring complimentary sequences of miRNAs in their 3′UTR in vivo in animals
as well as in vitro in cells. As miRNAs are involved in controlling bodily development
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and differentiation, monitoring of miRNA action will help
understand the physiological roles of miRNAs in the spatial
and the temporal development. Also, understanding miRNA
action might lead to the roles of miRNA action in neurological
or muscular disorders as well as cancer, autoimmunity,
inflammation, and other diseases (Kim, 2005; Krol et al., 2010).
MiR-124 is a well-known regulator responsible for
differentiation of progenitor cells to mature neurons. This
miRNA is increased during the embryonic stage followed by
stable expression in the post-natal period (Krichevsky et al.,
2003). The down-regulation of RE1 silencing transcription
factor (REST) inhibiting the expression of neuronal genes
in non-neuronal cells leads to induce miR-124 expression in
neural progenitor cells. This miR-124 degrades small C-terminal
domain phosphatase 1 (SCP1) which is a protein of anti-neural
function (Conaco et al., 2006; Visvanathan et al., 2007). In
neurogenesis, miR-124 down-regulates polypyrimidine tract
binding protein 1 (PTBP1) and Sox9 in the subventricular zone
(SVZ) (Makeyev et al., 2007; Cheng et al., 2009). Knockdown
of endogenous miR-124 maintains purified SVZ stem cells
as dividing precursors, whereas ectopic expression leads to
precocious and increased neuron formation formation (Cheng
et al., 2009; Åkerblom et al., 2012).
Measurements of miRNA expression by Northern blot, real-
time PCR, microarray, and in situ hybridization are all invasive
and used solely for ex vivo studies. However, these conventional
methods assessing only the amount of miRNA in the fixed
time point cannot provide functional action of miRNA over
time. To evaluate the miRNA biogenesis and action non-
invasively in living animals, in vivo optical imaging system
has been popularly used especially for mature miRNA action.
This optical reporter-based strategy to visualize miRNA action
as well as biogenesis was mainly performed using reporter-
transfected stem/progenitor cell grafts (Oh et al., 2013). If a
reporter gene containing the repeated complementary target
sequences of a miRNA is stably incorporated in embryo or
adult animal as a form of transgenic animal, this reporter
transcript will interact with endogenous miRNAs, leading to
the reduction of the reporter propensity and activity due to
the reporter mRNA cleavage or translational inhibition. Thus,
the endogenous miRNA action can be simply visualized in vivo
by fluorescence or bioluminescence imaging using fluorescent
proteins or luciferases.
Accumulating evidences using miRNA binding sequence-
engineered fluorescence reporter have been made to visualize
dynamic changes of miRNA level. The transgenic Drosophila
which contains two copies of perfectly complementary sequence
to bantam miRNA in the downstream of EGFP reporter
was reported as the first fluorescence reporter for in vivo
(Brennecke et al., 2003). In addition, dual fluorescence reporter
containing perfect target sequence for miR-430, miR-1, and
miR-133 was engineered to monitor the miRNA expression
pattern in the zebrafish embryo or mouse embryos (De Pietri
Tonelli et al., 2006; Giraldez et al., 2006; Mishima et al.,
2009). The lacZ reporter mouse model was designed for
detection of the presence of specific miRNAs (Mansfield et al.,
2004).
Fluorescence imaging has high background auto-fluorescence
and limited tissue penetration in vivo but bioluminescence
has almost absent background with much higher signal-
to-background ratio, better sensitivity and relatively deeper
penetration (Kim et al., 2009; Dong et al., 2013; Oh et al., 2013).
Here, we produced a miR-124 reporter transgenic mouse
containing miR-124-sensing luciferase reporter gene for tracing
the miR-124 action. The luciferase signal of miR-124 reporter
gene was significantly decreased by induction of exogenous miR-
124 in vitro. In vivo bioluminescence images were correlated with
miR-124 expression on real-time PCR in brain developmental
process and while luciferase was expressed variably in the
major organs of transgenic mice, luciferase activity of the brain
was correlated inversely with endogenous miR-124 expression.
Initially high and later dramatic decrease of the bioluminescence
in the brain of these transgenic mice are proposed to represent the
action of endogenous mature miRNA, i.e., miR-124 in neurons.
MATERIALS AND METHODS
Gene Constructs
The lentiviral vector was derived from pMSCV-ffLuc-pIRES2
-Thy1.1 (Rabinovich et al., 2008). The eﬄuc-eGFP-miR-
124_3 × PT vector was modified by inserting eGFP
into Thy1.1 between BamHI and BglII (Clontech,
Mountain View, CA, USA) and 3 tandem repeats of
miR-124 perfect target sequences (TTAAGGCACG
CGGTGAATGCC) into XhoI site. Viral vector for miR-124
overexpression experiment was derived from pSMPUW-miR-
GFP/Puro Lentiviral Expression Vector (Cell Biolabs, San Diego,
CA, USA). MiR-124 sequence was obtained from miR-124
precursor sequence including the 100 base flank sequences
on both ends of the stem loop from mouse genomic DNA
by PCR and clone the blunt-end PCR fragment into the
PshA I site of the expression vector. Primers were as follows:
forward 5′-tcgaggattcgactgtcctccctctcttccatc-3′, and reverse
5′-tcgagctagcgacttgtactgtgggcgcctgcag-3′. All constructs were
verified by sequencing.
Cell Culture and Transfection
HeLa cell lines were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Welgene, Korea) containing 10% fetal bovine
serum (FBS; Invitrogen, Carlsbad, CA, USA) and 1% Antibiotics-
antimycotics (Invitrogen, Carlsbad, CA, USA). Primary cortical
neurons were isolated from the cortex of E16 transgenic
mouse. The primary neurons were dissociated by 0.25% trypsin
and plated onto 6 well coated with 1 mg/mL poly-L-lysine.
Cortical neurons were grown in DMEM supplemented with N-2
(Invitrogen, Carlsbad, CA, USA), 0.3% Antibiotics-antimycotics
and 0.3% FBS in 5% CO2 incubator for DIV 10. The cells
were transiently transfected with 50 nM scramble, precursor
miR-124 or miR-124 inhibitor (Ambion, Austin, TX, USA)
using Lipofectamin 2000 (Invitrogen, New York, NY, USA). The
miR-124 inhibitor is chemically modified single-stranded RNA
molecule to bind endogenous miRNA-124 and enable miRNA
functional analysis by down-regulation of miRNA activity.
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Luciferase Assay
Cells were rinsed with phosphate-buffered saline (PBS, pH
7.4), reporter lysis buffer was added, and freeze-thaw cycle
was performed to ensure complete lysis. Luciferase activities
were measured by GloMaxr 96 Microplate Luminometer
(Promega, Fitchburg, WI, USA) according to the manufacturer’s
instructions of luciferase assay system (Promega, Fitchburg, WI,
USA).
Animals
To generate transgenic (Tg) mouse, we cut the eﬄuc-eGFP-miR-
124 3 × PT construct with NdeI and SalI, and ∼4.9 kb transgene
which included the 5′UTR and 3′UTR that was obtained from
vector. Purified transgene fragment was microinjected into the
pronuclei of fertilized C57BL/6N mouse embryos by Macrogen
Inc. (Seoul, Korea). Sixty-eight animals were screened and
two founders were identified to have the integrated transgene
by genotyping and luciferase activity. For genotyping, isolated
genomic DNA was tested by PCR analysis using specific
primers: forward 5′-GTGAGCAAGAAGGGCCTGCAGAA-3′
and reverse 5′-CCGCTGGTTCACGCCCAGGGTC-3′. Founders
were backcrossed to C57BL/6N mouse or intercrossed.
In vivo and Ex vivo Luciferase
Bioluminescence Imaging
All of the animal experimental procedures were approved by
Seoul National University Hospital Institutional Animal Care
and Use Committee [Approval number: 15-0050-C1A0(1)] and
performed in accordance with the guideline from the institute.
This institute cares animals in accordance with Association
for Assessment and Accreditation of Laboratory Animal Care
International (AAALAC International). All To the animals, we
administered 3 mg/0.1 mL/mouse luciferase substrate luciferin
(Caliper, Newton, MA, USA) intraperitoneally, and the animals
were sedated 15 mins after D-luciferin injection with 2.5%
isoflurane in O2 gas flowing through isoflurane/oxygen main tank
at a flow rate of 1.5 L/min. The bioluminescence images were
acquired for 10–600 s using IVIS-100 imaging system equipped
with a CCD camera (Xenogen, Alameda, CA, USA).
For ex vivo imaging of organs, the embryo and organs were
collected from anesthetized mouse after scanning the whole
body. The organs were exposed for 10 s in order to acquire
bioluminescence imaging. All image acquisition and data analysis
was conducted using Living image software (Xenogen, Alameda,
CA, USA).
MiRNA and mRNA Real-Time PCR
Total RNA was extracted from isolated organs with TRIzol
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s
instruction. 10 ng of RNA was processed for cDNA synthesis
using specific Taqman primer (Applied Biosystems, Carlsbad,
CA, USA) and M-MLV reverse transcriptase (Invitrogen,
Carlsbad, CA, USA). cDNA was then amplified on the 7500
real-time PCR system (Applied Biosystems, Carlsbad, CA, USA),
employing the11Ct method with Taqman assays to quantify the
relative expression level. MiRNA and mRNA level measurements
were done in triplicate for each experiment. The following
Taqman assays were used in this study: miR-124 (001182), and
U6 (001973).
Luciferase and GFP
Immunohistochemistry
Isolated organs were placed in 4% PFA for 48 h, and then made
into paraffin embedded tissue blocks. 4 µm paraffin sections
were deparaffinized by oven heating and by immersion in xylene.
After dehydration through graded alcohols to water, slides were
boiled in 0.01 M citrate buffer (pH 6.0) for 10 min then
maintained at a sub-boiling temperature for 20 min to retrieve
antigen, and further immersed in 1% H2O2 in methanol for
30 min. Sections were incubated for 30 min with TBS containing
0.5% Triton X-100 (TBST), before blocking each sections with
blocking solution (5% bovine serum albumin in TBST) for
30 min at room temperature. Sections were incubated at 4◦C
overnight with primary antibody against goat anti-luciferase
or GFP (Abcam, Cambridge, UK). After washing with TBST,
antibody staining was revealed using the species-specific Alexa
Flour 488 conjugated secondary antibody. 1 µM 4′.6-diamidino-
2-phenylindole (DAPI, Invitrogen, Carlsbad, CA, USA) was
used for counterstaining. Confocal microscopic observation was
performed using Carl Zeiss LSM510.
Immunocytochemistry
Cells were washed twice with PBS, and then fixed for 20 min
with 4% paraformaldehyde (PFA). After fixation, the cells were
incubated for 30 min in PBS containing 0.1% Triton X-100
for permeabilization, and then blocked by incubating the cells
in blocking buffer (3% normal goat serum, 2% BSA and 3%
Triton-X 100 in PBS) for 1 h at room temperature. Cells were
then incubated for overnight at 4◦C in PBS containing primary
antibodies against rabbit anti-MAP2 (Sigma, St. Louis, MO, USA)
and mouse anti-GFAP (Cell Signaling Technology, Danvers, MA,
USA). After washing with PBS, cells were incubated with Alexa
Flour 488- or 555-conjugated secondary antibody (Invitrogen,
Carlsbad, CA, USA) and 1 µM DAPI (Invitrogen, Carlsbad, CA,
USA) at room temperature. Stained cells were observed using a
confocal microscopy (Carl Zeiss LSM510, Jena, Germany).
Statistical Analysis
Data are expressed as the means ± SD values. One-way ANOVA
and Student’s t-test were used to determine statistical significance
where p< 0.05 was considered to be significant.
RESULTS
Production of miR-124 Action Reporter
Vector and Its Validation In vitro
In order to produce reporter construct for monitoring miR-
124 action (previous ID: miR-124a), we generated a construct
containing three copies of a miR-124-perfectly matched sequence
(miR-124_3 × PT) with the enhanced firefly luciferase (eﬄuc)
and enhanced GFP (eGFP) reporter genes in its 3′UTR. Using
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IRES (internal ribosome entry site) lentiviral vector, eﬄuc-eGFP-
miR-124_3 × PT construct co-expressed eﬄuc and GFP genes
from a single mRNA transcript. This allowed miR-124 to suppress
the expression of two reporter proteins (Figure 1A). In order
to validate the constructs, HeLa cells were co-transfected with
reporter construct and synthetic scramble or miR-124 precursors.
We found that miR-124 overexpression significantly affected
luciferase activity of eﬄuc-eGFP-miR-124_3 × PT-infected cells
by luciferase assay (5.37 ± 1.85%, p < 0.01, Figure 1B).
Eﬄuc-eGFP-miR-124_3 × PT construct was considered suitable
for monitoring miR-124 action as well as biogenesis, hence
generation of a new transgenic mouse for in vivo monitoring of
miR-124 using this construct was further investigated.
Generation of miR-124
Reporter-Harboring Transgenic Mice
Transgenic mice were produced by pronuclear injection of eﬄuc-
eGFP-miR-124_3 × PT gene using the CMV promoter to drive
the expression reporter transgenes in high amount. We tested
FIGURE 1 | MiR-124 action reporter vector and its validation.
(A) Schematic diagram of miR-124 reporter transgene of lentiviral vector. The
lentiviral construct consists of CMV promoter, effluc, IRES, and 3 × PT (triple
perfect targets) including three repeat perfect target sequences
complementary to mature miR-124. (B) Luminescence produced after 24 h of
transient transfection of scramble or miR-124 showed working of effluc in the
effluc-eGFP-miR-124_3 × PT transfected HeLa cells. Luciferase activity
(photons/second) was quantified using Living image software. Data are
represented by the means ± SEM (n = 3).
whether the transgenic mouse was able to carry out stable germ-
line transmission and inheritance. After D-luciferin injection, we
found two positive transgenic mice (line 18 and line 67) among
11 founders emitting bioluminescence signals. The origin mouse
of transgenic strain C57BL/6 mouse (wild type: wt) was used as
negative control (Figure 2A). High bioluminescence signal was
observed in the areas of hairless skin such as snout, ears, tail, and
feet. In whole body imaging, the bioluminescence was greater in
line 67 than in line 18 (Figure 2A). As shown in Figure 2B, the
bioluminescence was prominent throughout the whole body of
E16. Luciferase signals were also observed in the major isolated
organs of transgenic mice, compared to those of wt mouse, which
revealed that CMV promoter let the transgenes express in a
variety of mouse tissues and cells (Figure 2C). Interestingly, in
young adults, lung activity was the most prominent and removal
of hairs from the skin made skins shine (Figure 2C). Line 67
was used for further experiment of miR-124 imaging. In ex vivo
measurement of isolated organs of line 18, luciferase signals were
shown only in the skin but not in the major organs (data not
shown). There was no difference in miR-124 expression between
wt and transgenic mice in their various areas of the brains on
in situ hybridization analysis (Supplementary Figure S1). We
concluded that a line of transgenic mouse containing eﬄuc-
eGFP-miR-124_3× PT transgene was established.
Expression of miR-124 and Luciferase in
the Brain and the Other Organs of
Transgenic Mice
Real-time PCR was done with the total RNA of the brain
and other organs to determine the expression of miR-124. In
young adult mouse, miR-124 expression was approximately 100-
fold higher in the brain, compared to the other organs (lung,
heart, liver, kidney, and spleen) (Figure 3A). Luciferase was
detected using immunohistochemistry with transgenic embryo
sections and with major organs of the young adult mouse
(Figures 3B,C). In the whole body of E16, luciferase transgene
was expressed throughout the entire body (Figure 3B). The
distribution was uneven, but due to the difference of cell density
between organs, the relative density or rarity could not be
documented. In the young adults, luciferase counter-stained with
DAPI showed evenly distributed immunoreactivity in major
organs, among which the lungs showed the highest expression
(Figure 3C). As we expected, the luciferase was rarely seen
in the brain and was also barely seen in the liver in young
adult mice. This ex vivo study showed that luciferase was
expressed in other organs with the least miR-124 expression and
luciferase was suppressed in the brain (and liver) in young adult
periods.
Comparison of Luciferase
Bioluminescence and miR-124
Expression in the Brain during
Development
The pattern of miR-124 expression and luciferase reporter
bioluminescence was compared using brain tissues in each
period of E13, E16, P10, young and old adult with ex vivo
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FIGURE 2 | Bioluminescence images of candidate miR-124 reporter-expressing transgenic mice. (A) Whole body bioluminescence images of wt and
transgenic mice harboring effluc-eGFP-miR-124_3 × PT acquired with D-luciferin injection. The acquisition time of line 67 (left) and line 18 (right) was 10 s and 600 s,
respectively. (B) Ex vivo images of effluc reporter activity of fetuses of wt mouse and transgenic mice (line 67) at E16 period. (C) Ex vivo images of major organs
excised from a wt and a transgenic mouse (line 67).
luminescence imaging. At E13 period, the bioluminescence
of the brain was higher than that of the liver on luciferase
imaging but it decreased at E16, further at P10 and it was the
lowest in the young adult period (Figures 4A,B). In contrast,
bioluminescence of the liver was the highest at E16 and decreased
at P10 and it was the lowest in the young adult period
(Figures 4A,B).
Using brain lysates of each periods of E13, E16, P10, young
and old adult, on luciferase activity assay, luciferase activity was
highest at E13 and 17.1 ± 1.2% at E16 compared with at E13
and decreased further in the young adult period (Figure 4C).
Using the same lysates, on quantitative real-time PCR for miR-
124, miR-124 concentration was lowest at E13 and increased
continuously via E16 to the young adult period (Figure 4D).
When the relationship between ex vivo concentration of miR-124
and luciferase activity was plotted, it was found to be inverse-log-
log-proportional (Figure 4E).
Cortical Neurons Extracted from the
Transgenic Mouse Responded to
Transfected miR-124
Cortical neurons extracted from E16 transgenic mice were
cultured in vitro, and confirmed to have transgene genotypes
(data not shown). Under phase contrast microscope, these
neurons showed neuronal features along with lapsing
in vitro days until 10 days in vitro (DIV) (Figure 5A). On
immunocytochemistry using antibodies against MAP2 and
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FIGURE 3 | Validation of luciferase expression of a miR-124 reporter transgenic mouse. (A) In a young adult mouse, quantitative RT-PCR of tissue RNAs of
brain and major organs revealed prominent expression of miR-124 normalized to that of U6. The expression of other organs was represented using a fold increase
relative to the value 1 of the brain [means ± SD (n = 3)]. (B) At E16 period of a transgenic mouse, luciferase transgene expressed as shown and counterstained by
DAPI on whole body immunohistochemistry (C). Tissue sections of major organs of a transgenic mouse showed distribution of cells counterstained with DAPI (blue)
and propensity of luciferase staining (red). Compared with highest lung and moderate heart/kidney activities, luciferase of brain and liver was scarce on confocal
microscopy at 400× magnification. The scale bars represent 50 µm.
GFAP, which labeled mature neurons and astrocytes, respectively,
the proportion of primary cortical neurons was 94.9 ± 2.5%
(Figure 5B). When these cortical neurons were transfected
with scramble, miR-124 or miR-124 inhibitor for 24 h, miR-124
transfection alone significantly decreased the luciferase activity
by 55.3%, compared to scramble transfection (Figure 5C).
MiR-124 inhibitor did not change (increase) luciferase activity.
DISCUSSION
We produced a reporter transgenic mouse model harboring
eﬄuc-eGFP-miR-124_3 × PT transgene to visualize miR-124
action which plays an important role in neurogenesis under
physiological conditions. MiR-124 suppresses expression of
target mRNAs such as an anti-neural factor SCP1, transcription
factors Sox9, Notch ligand Jagged1, and the BAF53a subunit of
the chromatin-remodeling complex, and induces neurogenesis
during the neural development (Visvanathan et al., 2007; Cheng
et al., 2009; Yoo et al., 2009; Liu et al., 2011). Another target
of miR-124 is PTBP1 which has been recognized as a global
repressor of alternative pre-mRNA splicing in non-neuronal
cells. The reduced expression of PTBP1 promotes neuron-specific
alternative splicing of PTBP2, which is sufficient to decide the cell
fate toward the neuronal lineage (Makeyev et al., 2007; Xue et al.,
2013).
In order to design a construct that gets modulated by miR-124,
we inserted three repeats of perfectly matching complementary
sequences of mature miR-124 to the downstream of reporter
gene under the CMV promoter (Figure 1A). The luciferase gene
was used as a reporter gene due to high signal to background
ratios and relatively high tissue penetration (Kim et al., 2009; Oh
et al., 2013). The transgenic mice containing eﬄuc-eGFP-miR-
124_3 × PT transgene showed the bioluminescence signals in
major organs including the skin by the CMV promoter, which
is one of the strongest known promoters (Figures 2A,C). The
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FIGURE 4 | Developmental stage-dependent miR-124 expression regulates luciferase signal. (A) Ex vivo bioluminescence images of brain and liver of a
transgenic mouse along the bodily development in utero and after birth (E13 n = 6, E16 n = 6, P10 n = 3, young n = 3, and old n = 4); 3∼5 month old (young),
16∼24 month old (old). (B) Quantified results of these ex vivo images. Average counts of the brain and the liver was shown as photons/sec/cm2. The brain luciferase
was maximal at E13 and decreased to the minimum at young adult period and the liver luciferase was maximal at E16 and minimum at young adult period.
(C) Luciferase activity (RLU/mg) of brain lysate in each developmental stage. (D) Quantitative real-time RT-PCR results of mir-124 over U6 of the brain lysates in each
developmental stage. Data are shown as means ± SD. RLU/mg means relative light units per mg of protein of the lysate. (E) Relationship between miR-124
expression and luciferase activity of brain lysates which showed inverse relation. After log-log transform, the relation was inverse-proportional (inset). Whisker of each
point represents S.D.’s of miR-124 expression (abscissa) and luciferase activity (ordinate).
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FIGURE 5 | MiR-124 reduces luciferase activity in the cortical neurons extracted and cultured from transgenic mouse. (A) Cortical neurons from E16 of
transgenic mouse were cultured for 10 days in vitro (DIV). Images were displayed with phase-contrast microscope using 4× or 100× magnification (inset). The scale
bars represent 200 µm (low-scaled panel) and 50 µm (magnified panel). (B) Immunocytochemistry with anti-MAP2 (microtubule-associated protein-2, red, and
labeling neurons) and anti-GFAP (Glial fibrillary acid protein, green, and labeling astrocytes) antibodies counterstained with DAPI were shown with confocal
microscope using a 100× magnification. The scale bars represent 100 µm. 95% were MAP2 positive and the other 5% were GFAP positive. (C) Primary cultured
cortical neurons which were transfected with scramble, miR-124, or miR-124 inhibitor at DIV 10, showed reduction of luciferase activity only with miR-124. The
results were normalized as percent ratios to the scramble treatment. Data were represented by means ± SD (n = 6, ∗∗p < 0.01).
luciferase activity of glial cells, which do not express miR-124,
may contribute to the minimal bioluminescence of the brain
during young adult period (Figure 4A) when the expression of
miR-124 was maximal in brain mainly in neurons (Figures 3A
and 4D). However, green fluorescence was not observed in
any organs of transgenic mice, though we could find GFP
immunoreactivities in the tissues slices of transgenic mice which
should have expressed after the IRES segment (Supplementary
Figure S2, Ibrahimi et al., 2009). GFP immunoreactivities
in major organs of transgenic mouse were consistent with
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luciferase immunoreactivities (Supplementary Figure S2), which
were again consistent with bioluminescence imaging ex vivo
(Figure 2C). The observed action of miR-124 on the 3′UTR
of transgene transcript in this study proves that our transcript
worked to produce functionally active luciferase protein under
the expected regulation by endogenous miR-124 (Figure 4E).
We also observed bioluminescence of their embryos to confirm
integration and stable germ line transmission of the transgene
(Figure 2B).
On real-time PCR of miR-124 and immunohistochemical
analysis of luciferase, young adult transgenic mouse showed high
expression of miR-124 and low expression of luciferase in the
brain (Figures 3A,C). It has also been reported that miR-124
is expressed specifically in the nervous system (Conaco et al.,
2006; Makeyev et al., 2007; Visvanathan et al., 2007; Cheng et al.,
2009) and starts to increase in the brain at E10 period of mice
(Krichevsky et al., 2003; Farrell et al., 2011). In our study, miR-
124 expression reached the maximum in young adult period and
this increase was represented inversely well with measurement of
luciferase activity in tissue lysates (Figures 4C,D).
In our eﬄuc transgenic mouse, once we extracted the brain to
evade the high background luminescence of the skin, we could
easily visualize the intensity and distribution of luminescence
in the entire brain (Figure 4A). We observed changing
expressions of miR-124 in their brain of each developmental
stage by bioluminescence imaging, lysate luciferase assay and
real-time PCR. Interestingly, the amount of mature miR-
124 transcript and quantified luciferase activity on lysate
luciferase assay ex vivo were inversely log-log proportional.
As changing intensities of ex vivo bioluminescence imaging
of Figure 4A almost copied the changes of lysate luciferase
assay, ex vivo bioluminescence imaging predicted the amount
of miR-124 transcript of the brain. We propose that in vivo
bioluminescence imaging can also predict the amount of miR-
124 transcript in vivo without sacrifice of the animal. In
fact, in vitro real-time PCR yields only the amount of miR-
124 but not the action of mature miR-124 in vivo and
thus, we could say that luciferase bioluminescence or activity
represent the miR-124 action in situ as well as the amount of
miR-124.
Similar to the results reported here, neurogenesis occurs
at E9 to E10 and peaks at E14 to E15 in most parts of the
brain, and gradually decreases until birth (Götz and Huttner,
2005; Rowitch and Kriegstein, 2010; Díaz et al., 2014). MiR-124
induces neuronal differentiation and inhibits glial differentiation
of embryonic stem cells during this transition of neurogenesis
(Conaco et al., 2006; Makeyev et al., 2007; Visvanathan
et al., 2007; Åkerblom et al., 2012). This changing pattern of
neurogenesis associated with miR-124 is further supported by
our results, demonstrating an increase of the amount of miR-124
at E13 via E16 to the peak at young adult period (Figure 4D).
What, we have shown more in this investigation is that by
observing miR-124 action using luciferase bioluminescence, miR-
124 really acted as mature microRNA to suppress its target
proteins including our transgenes.
We also found that the organs with lower miR-124
expression than the brain showed variable levels of luciferase
on immunohistochemistry at E16 and in young adult period
(Figures 3B,C). The difference of luciferase expression among
the organs was assumed to be due to the different levels of
methylation of CMV promoter in each organ (Kong et al.,
2009). In a transgenic pig model expressing GFP driven by
a CMV promoter which was used to analyze the correlation
between the copy number and the promoter methylation, they
demonstrated that GFP mRNA amounts were almost 20-fold
higher in certain organs than those in other organs (Kong
et al., 2009). In our transgenic mouse model of line 67, the
lungs expressed the luciferase the highest amount and heart
and kidneys also expressed luciferase in high amounts. But,
in another model of line 18, all the internal organs expressed
almost no luciferase which could either mean silencing of CMV
promoter or suppression of luciferase by high miR-124 in these
organs. Considering absent expression of miR-124 in other
organs (Figure 3A), CMV promoter of the transgenes would have
been silenced in line 18 as well as in the other failed cases of
transgenic mouse production.
This transgenic mouse model can be a source for stem/
progenitor cells for transplantation. We extracted cortical
neurons from this transgenic mouse at E16 period and cultured
these cells. After administration of miR-124 to these cells,
luciferase of these cells was suppressed and thus, we could know
that the luciferase transgene mRNAs were under the control of
the exogenous miR-124 (Figure 5). We think that transgenic
mouse and derived cells are under good control of miR-124 and
luciferase transgene would work well to report the action of
mature miR-124. This implies that the lower luciferase expression
of the brain at E16 than at E13 but yet higher than adult
periods is sufficient to show further suppression of reporter
transgene expression by the extraneous abundant miR-124. We
propose that comparison of quantified bioluminescence after
directly injected or targeted delivery of miR-124 enable the
therapeutic efficacy of this targeted action using this eﬄuc-eGFP-
miR-124_3 × PT Tg mice. However, for quantitative in vivo
imaging, considering the ubiquitous expression of reporter
transgenes due to CMV promoter especially in skin which can
obliterate brain imaging, another transgenic mouse with a brain-
specific promoter might be generated as an improved alternative.
And the thickness of brain skull affects quantitative in vivo
bioluminescence imaging due to low rate of photonic emissions
under the skull. Thus, development of ultrasensitive luciferase
modification or new bioluminescence imaging device capable of
three-dimensional bioluminescence tomography is essential to
obtain high quality image signals.
The transgenic mice bearing the eﬄuc-eGFP-miR-124_3× PT
as well as transgenic mice bearing GFP-miR-124_4 × PT
of Akerblom’s group employ a signal-off system (Åkerblom
et al., 2012). If our or their transgenic mice will be the
source of donor stem/progenitor cells in cell transplantation
experiments, the difficulty of discrimination between cell death
or transgene silencing and signal-off when, we were trying
to determine whether the stem cells differentiate into the
neurons after implantation. To overcome this problem, signal-
on system using a fluorescent nanoparticle-based molecular
beacon with surface-bound nucleic acids (Hwang et al., 2010) was
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proposed to monitor microRNA action in vivo and thus
transfection of the stem/progenitor cells using molecular beacons
will be necessary for further experiment (Tyagi and Kramer,
1996).
Åkerblom et al. (2012) have demonstrated a miR-124 sensor
transgenic mouse containing GFP-miR-124 4× PT and used this
transgenic model to show that miR-124 overexpression induces
neuronal differentiation from neural stem cells, promoting
neurogenesis in SVZ. They also showed that the inhibition of
miR-124 via sponge expression blocks neurogenesis, leading to
the development of ectopic cells with astrocyte characteristics
in the olfactory bulb (Åkerblom et al., 2012). We propose
that unlike miR-124-sensing GFP transgenic mice, we could
quantify luciferase activity using bioluminescence imaging which
was inversely correlated with miR-124 level in the brain. This
model mouse can be used for monitoring dynamics of miR-124
repeatedly in vivo and after the last imaging, confirmation of the
results are possible using ex vivo bioluminescence imaging and
the classical luciferase assay and RT-PCR of the lysates and in
situ hybridization and immunohistochemistry. This model can
also be used for proving the success of miRNA or siRNA delivery
to the neurons by observing the action of miRNA/siRNA against
miR-124 targets in vivo.
CONCLUSION
We produced a transgenic mouse and proved that luciferase
transgenes in the brain as well as the other organs are
under endogenous miR-124 control using real-time RT-
PCR, luciferase activity assay using lysates, and luciferase
imaging ex vivo as well as in vivo and finally proven by
immunohistochemistry. Most importantly, in vivo action of
miR-124 was represented by luciferase bioluminescence imaging
associated with quantification. Using this miR-124 reporter
mouse, miR-124 was expressed in a changing fashion during
development in utero and after birth, which recapitulated
previous studies about the role of miR-124 in neurogenesis. This
animal model can be used to investigate the role of miR-124
in various physiological and pathologic conditions. The final
outcome of successful delivery of therapeutic miRNA/siRNA
can now be evaluated non-invasively to demonstrate the
biodistribution of its action (not just the delivery) following
systemic or topical delivery of miRNA by observing the action
of these therapeutic nucleic acids in transgenic animals.
In our eﬄuc transgenic mouse, we extracted the mouse brain
to minimize the high background signal from the skull, and
we could easily visualize the signal intensity and distribution
of bioluminescence in the entire brain (Figure 4A). Indeed,
unlike fluorescence imaging that has intrinsic limitation such
as high non-specific background due to the requirement of
external light source, bioluminescence imaging that does not use
excitation light can offer better imaging quality. Nevertheless,
the thickness of brain skull may hamper the good penetration
of emitted light from luciferase-luciferin reaction, decreasing
signal sensitivity. Thus, development of ultrasensitive luciferase
modification or new bioluminescence imaging device capable of
three-dimensional bioluminescence tomography is essential to
obtain high quality image signals.
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FIGURE S1 | MiR-124 was expressed well after reporter insertion in the
brain of transgenic mouse at young adult period. The expression pattern was
not different between wt and transgenic mouse in that all the in situ histochemical
activity resided in the neurons of cortex (CTX), hippocampal cortex (HC), striatum
(STR), rostral migratory stream (RMS), and SVZ.
FIGURE S2 | GFP expressions in major organs of transgenic mouse were
measured by immunohistochemistry using anti-GFP (green), and
counter-stained the sections with DAPI (blue). GFP immune reactivities in
major organs of Tg mouse were compared with luciferase immunoreactives.
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